- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: Afrezza and MNKD
Posted on 4/7/14 at 8:12 am to Boudin
Posted on 4/7/14 at 8:12 am to Boudin
Aaaaand FDA not folding that easy. Extended review for 3 more months to do more in depth research.
FDA really doesn't want to do this one. Will see 20% or so sell off today IMO.
FDA really doesn't want to do this one. Will see 20% or so sell off today IMO.
This post was edited on 4/7/14 at 8:13 am
Posted on 4/7/14 at 9:57 am to donRANDOMnumbers
yeap, this is really an episode of house of cards corruption style. FDA bigwigs probably thought the panel would vote no or much closer. What is the real tell and had me confused was the lack of bounce post panel vote. I though it would jump much higher. Now they got 3 months to F things up for MNKD but i still don't see how it doesn't' get passed. Why the hate for MNKD by the FDA. For starters, the FDA head husband runs a big bio tech fund, lots of shorts in MNKD. Than throw in big pharm who throw around lots of donations doesn't want to lose money to the upstart therapy. If you can't beat join them, MNKD probably sells out, so i like the buy.
Popular
Back to top
![logo](https://images.tigerdroppings.com/images/layout/TDIcon.jpg)